Skip to main content
Log in

Studies on the autonomic nervous system in borderline hypertension

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Parameters of the autonomic nervous system were studied in normotensive subjects (NT; standing blood pressure (BP)≤125/85 mmHg) and in subjects with borderline hypertension (BHT; 140/90≤standing BP<60/100 mmHg). No differences in plasma noradrenaline and adrenaline levels were found between NT and BHT subjects, neither at rest nor during exercise at 75% of maximum work capacity. The dose of noradrenaline required to increase systolic BP by 10 mmHg was significantly higher in NT than in BHT subjects (5.13±0.42 vs 3.50±0.57 µg · min−1). No difference between NT and BHT subjects was found in the dose of isoprenaline required to increase heart rate by 20 beats · min−1 (1.21±0.12 vs 1.09±0.11 µg · min−1). Resting salivary flow was significantly lower in BHT than in NT subjects (0.39±0.06 vs 0.98±0.06 g · min−1), suggesting decreased parasympathetic activity in the former group. The enhanced pressor effect of noradrenaline, together with the decreased parasympathetic activity, could explain the elevated blood pressure and heart rate in subjects with borderline hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Henquet JW, Kho T, Schols M, Thijssen H, Rahn KH (1981) The sympathetic nervous system and the renin-angiotensin system in borderline hypertension. Clin Sci 60: 25–31

    Google Scholar 

  2. Sannerstedt R (1966) Hemodynamic response to exercise in patients with arterial hypertension. Acta Med Scand 180 [Suppl] 458: 1–83

    Google Scholar 

  3. Lund-Johansen P (1967) Hemodynamics in elderly essential hypertension. Acta Med Scand 183 [Suppl] 482: 1–101

    Google Scholar 

  4. Julius S, Conway J (1968) Hemodynamics in patients with borderline pressure elevation. Circulation 38: 282–288

    Google Scholar 

  5. Julius S, Ellis CN, Pascual AV, Matice M, Hansson L, Hunyor SN, Sandler NL (1974) Home blood pressure determination values in borderline (“labile”) hypertension. J Am Med Assoc 229: 663–666

    Google Scholar 

  6. Dollery CT, Daires DS, Draffan GH, Dargie HJ, Dean CR, Reid JL, Clare RA, Murray S (1976) Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther 19: 111–117

    Google Scholar 

  7. Weidmann P, Grimm M, Meier A, Glück Z, Keusch G, Minder I, Beretta-Piccoli C (1980) Pathogenic and therapeutic significance of cardiovascular pressor reactivity as related to plasma catecholamines in borderline and established essential hypertension. Clin Exp Hypertens 2: 427–449

    Google Scholar 

  8. Goldenberg M, Pines KL, Baldwin E de F, Greene DG, Roh CHE (1948) The hemodynamic response of man to norepinephrine and epinephrine and its relation to the problem of hypertension. Am J Med 5: 792–806

    Google Scholar 

  9. Doyle AE, Fraser JRE, Marshall MJ (1959) Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects. Clin Sci 18: 441

    Google Scholar 

  10. Mendlowitz M, Meyer A (1955) Effect of vasodilatation and vasoconstriction on flow pressure ratio's in the digital circulation in normotensive and hypertensive subjects. Fed Proc 14: 100

    Google Scholar 

  11. Philipp Th, Distler A, Cordes U (1978) Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet 2: 959–963

    Google Scholar 

  12. Julius S, Esler MD, Randall OS (1975) Role of the autonomic nervous system in mild human hypertension. Clin Sci Mol Med 48: 243S-252S

    Google Scholar 

  13. London GM, Safar ME, Weiss YA, Milliez PL (1976) Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients. J Clin Pharmacol 16: 174

    Google Scholar 

  14. McAllister Jr RG, Love DV, Guthrie P, Dominic JA, Kotchen TA (1979) Peripheral beta-receptor responsiveness in patients with essential hypertension. Arch Intern Med 139: 879–881

    Google Scholar 

  15. Bertel O, Bühler FR, Kiowski W, Lütold BE (1980) Decreased beta-adrenoceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 2: 130–138

    Google Scholar 

  16. Julius S, Pascual AV, London R (1971) Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 44: 413–418

    Google Scholar 

  17. Reid JL, Wing LMH, Mathias CJ, Frankel HL, Neill E (1977) The central hypotensive effect of clonidine. Clin Pharmacol Ther 21: 375–381

    Google Scholar 

  18. Emmelin N (1967) Nervous control of salivary glands. In: Code CF (ed) Handbook of physiology, Section 6, vol II. Am Physiol Soc, Washington, pp 595–632

    Google Scholar 

  19. Schneyer LH, Schneyer CA (1967) Inorganic composition of saliva. In: Code CF (ed) Handbook of physiology, Section 6, vol II. Am Physiol Soc, Washington, pp 497–530

    Google Scholar 

  20. Gjörstrup P (1977) Effects of sympathetic nerve stimulation in the presence of a slow parasympathetic secretion in the parotid and submaxillary glands of the rabbit. Acta Physiol Scand 101: 211–218

    Google Scholar 

  21. Ørstavik TB (1978) The distribution and secretion of kallikrein in some exocrine organs of the rat. Acta Physiol Scand 104: 431–442

    Google Scholar 

  22. Robinson BF, Epstein SE, Beiser GD, Braunwald E (1966) Control of heart rate by the autonomic nervous system. Studies in men on the interrelation between baroreceptor mechanisms and exercise. Circ Res 19: 400–411

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henquet, J.W., van Baak, M., Schols, M. et al. Studies on the autonomic nervous system in borderline hypertension. Eur J Clin Pharmacol 22, 285–288 (1982). https://doi.org/10.1007/BF00548394

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00548394

Key words

Navigation